New Results
Recurrent phases of strict protein limitation inhibit tumor growth and restore lifespan in a Drosophila intestinal cancer model
Roxana M. Pfefferkorn, Benedikt M. Mortzfeld, Christine Fink, Jakob von Frieling, Judith Bossen, Daniela Esser, Christoph Kaleta, Philip Rosenstiel, View ORCID ProfileHolger Heine, Thomas Roeder
doi: https://doi.org/10.1101/2023.01.18.524563
Roxana M. Pfefferkorn
1Department of Molecular Physiology, Zoological Institute, Kiel University, Kiel, Germany
Benedikt M. Mortzfeld
2Department of Cell and Developmental Biology, Zoological Institute, Kiel University, Kiel, Germany
Christine Fink
1Department of Molecular Physiology, Zoological Institute, Kiel University, Kiel, Germany
Jakob von Frieling
1Department of Molecular Physiology, Zoological Institute, Kiel University, Kiel, Germany
Judith Bossen
1Department of Molecular Physiology, Zoological Institute, Kiel University, Kiel, Germany
Daniela Esser
3Department of Neuroimmunology, Institute of Clinical Chemistry, University Medical Center Schleswig-Holstein, Kiel
Christoph Kaleta
4Department Medical Systems Biology, Institute for Experimental Medicine, Kiel University, Germany
Philip Rosenstiel
5Department Molecular Cell Biology, Institute for Clinical Molecular Biology, Kiel University, Germany
Holger Heine
6Division of Innate Immunity, Research Center Borstel – Leibniz Lung Center, Borstel, Germany
Thomas Roeder
1Department of Molecular Physiology, Zoological Institute, Kiel University, Kiel, Germany
Posted January 20, 2023.
Recurrent phases of strict protein limitation inhibit tumor growth and restore lifespan in a Drosophila intestinal cancer model
Roxana M. Pfefferkorn, Benedikt M. Mortzfeld, Christine Fink, Jakob von Frieling, Judith Bossen, Daniela Esser, Christoph Kaleta, Philip Rosenstiel, Holger Heine, Thomas Roeder
bioRxiv 2023.01.18.524563; doi: https://doi.org/10.1101/2023.01.18.524563
Recurrent phases of strict protein limitation inhibit tumor growth and restore lifespan in a Drosophila intestinal cancer model
Roxana M. Pfefferkorn, Benedikt M. Mortzfeld, Christine Fink, Jakob von Frieling, Judith Bossen, Daniela Esser, Christoph Kaleta, Philip Rosenstiel, Holger Heine, Thomas Roeder
bioRxiv 2023.01.18.524563; doi: https://doi.org/10.1101/2023.01.18.524563
Subject Area
Subject Areas
- Biochemistry (11703)
- Bioengineering (8722)
- Bioinformatics (29127)
- Biophysics (14932)
- Cancer Biology (12048)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14143)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12220)
- Genomics (16766)
- Immunology (11841)
- Microbiology (28005)
- Molecular Biology (11552)
- Neuroscience (60808)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4939)
- Plant Biology (10384)
- Synthetic Biology (2877)
- Systems Biology (7333)
- Zoology (1642)